» Articles » PMID: 22863689

Vitamin D in Children with Cystic Fibrosis

Overview
Journal Arch Dis Child
Specialty Pediatrics
Date 2012 Aug 7
PMID 22863689
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The Cystic Fibrosis Trust in 2007 published a recommended target of 75-150 nmol/L for 25-hydroxyvitamin D (25-OHD). In 2008 we found that only 10% of pancreatic insufficient (PI) children met this target. An increase in supplementation was implemented and a repeat audit performed in 2010.

Methods: PI children ≥1 year under sole-care in our regional centre were included. Vitamin D3 supplementation increased by >450% to either 3800 IU/day liquid or 800 IU daily plus 20,000 IU weekly tablets. In 2010 pancreatic sufficient (PS) children were also audited separately.

Results: The median 25-OHD level increased from 51.5 nmol/L in 2008 (n=78, 10% >75 nmol/L) to 72 nmol/L in 2010 (n=72, 51% >75 nmol/L), p<0.0001. In PS children (n=15 in 2010) 87% had 25-OHD levels <75 nmol/L.

Conclusions: A substantial increase in supplementation led to a significant increase in 25-OHD levels but around half still failed to reach the recommended target.

Citing Articles

Update on the management of vitamins and minerals in cystic fibrosis.

Sankararaman S, Hendrix S, Schindler T Nutr Clin Pract. 2022; 37(5):1074-1087.

PMID: 35997322 PMC: 9544449. DOI: 10.1002/ncp.10899.


Treatment of cystic fibrosis related bone disease.

Ullal J, Kutney K, Williams K, Weber D J Clin Transl Endocrinol. 2022; 27:100291.

PMID: 35059303 PMC: 8760456. DOI: 10.1016/j.jcte.2021.100291.


Vitamin D Status in Pediatric and Young Adult Cystic Fibrosis Patients. Are the New Recommendations Effective?.

Mangas-Sanchez C, Garriga-Garcia M, Serrano-Nieto M, Garcia-Romero R, Alvarez-Beltran M, Crehua-Gaudiza E Nutrients. 2021; 13(12).

PMID: 34959965 PMC: 8703649. DOI: 10.3390/nu13124413.


Are Vitamin D Tablets and Oil Drops Equally Effective in Raising S-25-Hydroxyvitamin D Concentrations? A Post-Hoc Analysis of an Observational Study on Immunodeficient Patients.

Helde Frankling M, Norlin A, Hansen S, Wahren Borgstrom E, Bergman P, Bjorkhem-Bergman L Nutrients. 2020; 12(5).

PMID: 32357579 PMC: 7282031. DOI: 10.3390/nu12051230.


Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.

Siwamogsatham O, Alvarez J, Tangpricha V Curr Opin Endocrinol Diabetes Obes. 2014; 21(5):422-9.

PMID: 25105995 PMC: 4326081. DOI: 10.1097/MED.0000000000000096.